# CB Health Ventures

> CB Health Ventures is a VC fund in Boston backing Health Care and Biotechnology. See 46 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Boston, United States
- Total investments: 46
- Last investment: Jan 2021
- Lead investor: 2%
- Last fund: Mar 2008
- Last updated: Aug 2026
- X (Twitter): https://www.twitter.com/excelventure
- Website: http://www.health-ventures.com/home.htm

CB Health Ventures is a VC fund in Boston focused on Health Care and Biotechnology. CB Health Ventures manages $150 million of private equity funds focused on investment opportunities in healthcare services, medical information technology, biotechnology and genomics. CB Health Ventures leverages its access to decision-makers at hundreds of healthcare providers and payers to create value for its investors and the owners of itsportfolio companies.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 24 | 52% |
| Biotechnology | 15 | 33% |
| Medical | 9 | 20% |
| Health Diagnostics | 6 | 13% |
| Software | 5 | 11% |

42 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 14 | 30% |
| Series A | 7 | 15% |
| Series B | 7 | 15% |
| Series C | 6 | 13% |
| Series E | 3 | 7% |

8 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Neosensory | Neosensory focus on sending a variety of data streams to the brain via the sense of touch. With so much unused real estate on the body, the skin presents huge potential for the delivery of new information. They are currently building the world’s first hearing assistive technology that enables people to listen with their skin. |  | Private Equity | Jan 01, 2021 |  |
| Orionis Biosciences | Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation.The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initialinternal focus in oncology and immunotherapies.Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution. |  | Private Equity | Jan 01, 2021 |  |
| Gemphire Therapeutics | Gemphire Therapeutics manufactures and markets Gemcabene, an LDL cholesterol-lowering medication. It is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH. The company was founded in 2014 and is based in Northville, Michigan. |  | Private Equity | Jan 01, 2020 |  |
| Oculus Health | Oculus Health provides the support, insights, and passion needed for primary care and specialty providers to be successful in a changing health care environment. They improve patient outcomes and bring joy back to the practice of medicine, all while growing your revenues. |  | Private Equity | Jan 01, 2020 |  |
| Openwater | Openwater is developing a new generation of imaging technologies, with high resolution and low costs, enabling medical diagnoses and treatments, and a new era of fluid and affordable brain-to-computer communications |  | Seed | Mar 01, 2018 |  |
| InfoBionic | InfoBionic transforms the efficiency and the economics of ambulatory remote patient monitoring processes and cardiac diagnostic services by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. It has developed the MoMe System, a remote patient monitoring platform initially focused on cardiacarrhythmia detection, to improve clinical efficiency and patient care with any time, anywhere access to patient data. The company was founded in 2011 and is headquartered in Waltham, Massachusetts. | $6M | Private Equity | Jan 01, 2017 |  |
| ClearDATA | Healthcare professionals across the globe trust the ClearDATA HITRUST-certified cloud to safeguard their sensitive data and power their critical applications available across the major public cloud platforms. For healthcare organizations, customers receive one of the most comprehensive Business Associate Agreements (BAA) in the industry, combinedwith market-leading healthcare-exclusive security and compliance solutions, and multi-cloud expertise. ClearDATA’s innovative platform of solutions and services protects customers from data privacy risks, improves their data management, and scales their healthcare IT infrastructure, enabling the industry to focus on making healthcare better by improving healthcare delivery, every single day. |  | Private Equity | Jan 01, 2017 |  |
| BIOCIUS Life Sciences | BIOCIUS Life Sciences, Inc. engages in the drug discovery research. The company was incorporated in 2009 and is based in Woburn, Massachusetts. BIOCIUS Life Sciences, Inc. operates as a subsidiary of BioTrove, Inc. |  | Private Equity | Jan 01, 2015 |  |
| Qstream | Qstream is a microlearning platform that quantifiably improves job proficiency and changes behavior that results in teams who excel. The company specializes in the fields of analytics, enterprise software, health care, and medical device. The company was founded in 2008 and headquartered in Burlington, Massachusetts. |  | Private Equity | Jan 01, 2014 |  |
| N-of-One | N-of-One Therapeutics provides cancer care services. Its team of clinicians and scientists works with a network of diagnostic laboratories, research institutions, and cancer experts to provide access to cancer research, medical science, and molecular diagnostic testing. The company conducts research to assess the standard of care and otherdiagnostic and treatment opportunities for various cancer types. |  | Private Equity | Jan 01, 2014 |  |

10 of 46 investments shown.

## Co-investors
- [Excel Venture Management](https://shizune.co/investors/profile/excel-venture-management) — VC Fund, 7 deals together
- Zero Stage Capital — VC Fund, 6 deals together
- [Flagship Pioneering](https://shizune.co/investors/profile/flagship-ventures) — VC Fund, 5 deals together
- POSCO BioVentures — VC Fund, 5 deals together
- [3i Group](https://shizune.co/investors/profile/3i-group) — VC Fund, 4 deals together
- Sherbrooke Capital — VC Fund, 4 deals together

## Similar investors

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

## FAQ

### What does CB Health Ventures invest in?

CB Health Ventures invests primarily in Health Care, Biotechnology and Medical startups, most often at Private Equity and Series A stage. Most of the 46 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did CB Health Ventures last invest?

The most recent investment recorded for CB Health Ventures closed in Jan 2021. Shizune tracks 46 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co